Alectinib Alecensa 150 Mg Capsules

About Alectinib Alecensa 150 Mg Capsules

Alectinib 150 mg Capsules (Alecensa) is a targeted anti-cancer medication used for the treatment of ALK-positive non-small cell lung cancer (NSCLC). It belongs to a class of drugs known as ALK inhibitors, which work by blocking abnormal proteins that promote the growth of cancer cells.

This medicine is widely prescribed for patients whose cancer has spread to other parts of the body or has not responded to prior treatments. Alectinib is known for its effectiveness in controlling disease progression and improving patient outcomes, including activity against brain metastases.

• Effective in ALK-positive NSCLC treatment
• Helps slow down or stop cancer cell growth
• Shows strong central nervous system (CNS) activity
• Oral capsule form for convenient administration
• Globally trusted brand by Roche

• To be taken strictly as per doctors prescription
• Usually administered twice daily with food
• Dosage may vary based on patient condition and response

• Store below 30C
• Keep in a dry and cool place
• Protect from direct sunlight

• Use under medical supervision only
• Not recommended during pregnancy or breastfeeding
• Inform doctor about any existing liver or lung conditions
• Possible side effects: fatigue, constipation, swelling, muscle pain